False Certification and Implied Certification: What the Government Was Really Paying For

False Claims Act false certification involves a request for government money backed by a false compliance statement or a misleading omission about something that matters to payment. The signature may be on a certification form. The representation may also be inside a billing code, a product description or a claim for a particular service. If you know what the company promised and what it actually supplied, you may see the difference that the person approving payment never saw.

What did the company say? What did it leave out? Who knew? And why did the truth matter to the government paying the bill?

False Billing, Express Certification and Implied Certification

False billing misstates what the government is buying: the service, its quantity, the provider or the level of care. Express certification affirmatively states that a requirement has been met. Implied certification concerns a payment representation that becomes misleading because the company leaves out a material failure to meet a requirement.

A false certification can hide the gap between that promise and what was delivered. What the company knew and why the truth mattered to payment connect that gap to a False Claims Act case.

A health care claim can name a service that took place while concealing that the person providing it lacked the qualifications the claim represented. A product can arrive with a certificate describing compliance that the manufacturing records contradict. The work happened. The question is what the government was led to believe it was paying for.

When the Certification Is Express

An express false certification affirmatively misrepresents compliance with a requirement that matters to payment. It may sit in the paperwork accompanying a product, rather than on the invoice itself. That makes the people who manufacture, inspect and release the product important to understanding the claim.

A whistleblower’s complaint against United Airlines described hydraulic lines that allegedly leaked after manufacture with an uncertified tool. Yet the company allegedly put them into serviceable inventory. The complaint described the accompanying certification:

The complaint alleged that United received additional payment for each hydraulic line created or serviced with that tool, beyond its base contract. We see the absurdity in that allegation: the tag promised approved manufacturing while the lines leaked. Serviceable on paper. The tool, the finished line, the tag and the payment each tell a part of the story we examine with an insider.

The Invoice May Go Through Someone Else

The payment connection can run through another business or a public agency. In its 2009 report, Qui Tam: The False Claims Act and Related Federal Statutes, the Congressional Research Service explained that the law reaches qualifying claims paid directly or indirectly from federal funds.

The highway-product case involving Trinity Industries shows that chain in practice. Invoices referenced shipping documents that sometimes carried certificates of compliance with crash-testing standards. State transportation departments could seek federal reimbursement for the systems. The alleged false representation traveled with the product before the federal reimbursement request.

When the Certification Is Implied

Implied certification can support a False Claims Act case when a payment request describes specific goods or services but leaves out a failure that makes that description misleading. The hidden failure must matter to payment. The Supreme Court recognized this route in its 2016 Universal Health Services decision.

Universal Health Services faced allegations about a mental health clinic’s Medicaid billing and provider codes. Those codes represented particular counseling services and types of professionals. The whistleblowers alleged that the claims concealed failures involving staff qualifications, licensing and supervision. They alleged that Medicaid paid without knowing about those deficiencies.

A code can say a great deal. It can tell the payer both what treatment occurred and who was qualified to provide it. The alleged omission changed the meaning of the information submitted for payment. A provider’s billing language can promise something its staffing records contradict.

A Drug Name Can Carry the Representation

Gilead Sciences faced allegations that the names on its reimbursement claims represented approved drugs while concealing the use of an unapproved source for an active ingredient. Former employees alleged that the company used ingredient made at unregistered Chinese facilities while representing that it came from an approved South Korean manufacturer.

The Ninth Circuit’s 2017 opinion explains why the product names mattered. Claims for Truvada, Emtriva and Atripla represented specific medications under the Food and Drug Administration’s approval system. The whistleblowers alleged that Gilead relabeled the ingredient to conceal its source and falsified test results showing contamination.

For someone in pharmaceutical quality assurance, the connection is recognizable: the approved manufacturing site, the actual supplier, the batch tests and the drug identified in the payment request.

What Makes a False Certification Material?

A false certification is material when it could change whether the government pays. The requirement’s importance to the purchase, the information the payer had and the payer’s response all matter.

We look at why a requirement mattered to the purchase, whether or not the form called it a condition of payment. The word required on a form cannot do all that work.

The government’s response helps explain what mattered to it. Continued payment is something we work through with an insider: what information reached the responsible agency, when it arrived, and whether the disputed practice continued.

What Was Behind the Continued Payment?

Trinity’s guardrail case shows why the agency’s response matters. The Federal Highway Administration examined the modified product and maintained its eligibility for reimbursement. In its 2017 decision for Trinity, the Fifth Circuit overturned the trial judgment because the evidence failed to establish materiality. The agency had affirmatively stood behind reimbursement after examining the issue.

Gilead also pointed to continued approval and government payment. But the Ninth Circuit found unresolved questions about exactly what the government knew and when. It identified possible reasons for continued drug approval apart from whether the government had paid for nonconforming drugs.

The court also distinguished payments after Gilead stopped using the disputed supplier from payments during the alleged noncompliance. That was the court’s analysis of the allegations. Timing changed what continued payment could tell it about the government’s response.

These decisions show why we look behind the phrase the government kept paying. An agency’s examination and affirmative decision carry more meaning than an unexplained payment entry in a ledger.

For an insider, the useful connection runs from the exact discrepancy to the information the payer received and the decision it made. An inspection report, an agency response and the dates of the affected claims can explain much more than the payment history alone.

What the Company Knew When It Made the Claim

Knowledge concerns the company’s understanding when it made the claim. In its 2023 decision involving SuperValu and Safeway, the Supreme Court focused on what the defendants actually understood when they submitted their claims. An explanation invented afterward does not erase an earlier belief that the claim was false.

The Gilead allegations put that question inside the business. The former employees alleged changes to test results, batch numbers and inventory-control numbers, along with representations that ingredient from unapproved facilities came from approved ones. Those allegations concerned actions that would hide the discrepancy from the people relying on the paperwork.

We connect a certification to the records behind it and the decisions made before submission. A warning about qualifications matters differently when the person approving the claim received it. An internal test result matters differently when the report sent outside the company says the batch passed. The sequence can show who knew the representation was wrong and how it reached the payment system.

Fraudulent Inducement: When the False Promise Wins the Business

Fraudulent inducement concerns deception that gets the government to award the contract in the first place. A contract obtained through fraud can affect later payment claims even when those invoices accurately describe the work performed.

That directs attention to an earlier decision: what representation persuaded the government to award the work or admit the company to the funded program? In the Gilead case, the whistleblowers alleged that false representations used to obtain approval affected the later claims for payment. The application, approval, product and reimbursement request belonged to the same alleged course of conduct.

We work through those connections with the person who knows the business. Someone may see the certification, someone else the test result, and someone else the claim. The case depends on how those records and decisions fit together.

A whistleblower case under the False Claims Act, called a qui tam case, can pay 15% to 30% of what the government recovers.

When You Know What the Certification Conceals

If you know why a certification, billing code or product description tells a different story from the work behind it, speak with our whistleblower experts about that difference. We work beside you to build your strongest False Claims Act case around the representation, the payment and the people who knew, and bring in False Claims Act whistleblower lawyers with the healthcare or government-contracting experience your evidence calls for. You bring the knowledge of the business; we bring the expertise and partnership to pursue it with you.